Japan's Takeda Pharmaceutical hit with $6bn Actos damages bill

Actos box Takeda Pharmaceutical's Actos drug for treating diabetes has been the target of thousands of lawsuits

Related Stories

A US jury in Louisiana has ordered Japanese firm Takeda Pharmaceutical to pay $6bn (£3.6bn) in punitive damages, over claims it was hiding cancer risks associated with diabetes drug Actos.

US firm Eli Lilly, a co-defendant in the case, has been ordered to pay $3bn in punitive damages.

Takeda's shares fell by about 9%, their biggest drop in five years, following the ruling.

The drugmaker said it "respectfully disagrees with the verdict".

Earlier this week, the same jury awarded $1.5m in compensatory damages to plaintiff Terrence Allen.

In his lawsuit, Mr Allen alleged that Takeda was aware of the link between Actos and bladder cancer early in the decade, but chose to withhold the information from consumers and the healthcare industry.

Mr Allen was diagnosed with bladder cancer in January 2011. He was using the Actos drug from 2004 to 2011.

Lawsuits pending

In a statement, Takeda said it intended to "vigorously challenge this outcome through all available legal means, including possible post-trial motions and an appeal".

"We have empathy for the Allens, but we believe the evidence did not support a finding that Actos caused his bladder cancer. We also believe we demonstrated that Takeda acted responsibly with regard to Actos."

Mr Allen's lawyer, Mark Lanier, has acknowledged he is uncertain whether the damages will be upheld.

He said: "No one has gone out and bought a new home. We're not under any grand illusion."

Mr Allen's case is the first of more than 2,500 Actos lawsuits pending in the US federal court system, which all involve similar allegations that Takeda Pharmaceuticals failed to give adequate warnings to users or the medical community about the risk of bladder cancer from Actos.

In May 2013, a California jury awarded $6.5m in damages over claims of an Actos-related bladder cancer. But a judge reversed the verdict later and threw out the claim.

FDA warning

Takeda started selling Actos in the US in 1999. US firm Eli Lilly and Takeda co-promoted Actos from 1999 to 2006.

According to court documents, Actos has generated more than $16bn in sales since 1999.

The US Food and Drug Administration (FDA) announced in 2011 that using Actos for more than one year could be associated with an increased risk of bladder cancer.

Governments in France and Germany banned Actos after the FDA's announcement.

More on This Story

Related Stories

The BBC is not responsible for the content of external Internet sites

More Business stories


Business Live

    06:28: Radio 5 live

    The Bank of England's Martin Weale has been telling Wake Up to Money why he's been voting for interest rates to move off the record low of 0.5%. "It isn't only that unemployment has been falling - at least until recently extremely rapidly. It's also that when I go and visit businesses throughout the country I find they're talking of pay increases in a way quite different from what I was hearing early in the year certainly this time last year."

    06:16: Markets Radio 5 live

    Brenda Kelly from IG is Wake Up to Money's markets guest. They are talking about the falling oil prices. "A lot of it is down to a glut of supply and Saudi Arabia wants to keep market share," she says. Saudi's breakeven price is only a few dollars per barrel.

    06:10: Christmas spending Radio 5 live

    Mark Barnett, UK & Ireland president of Mastercard, is on Wake Up to Money, talking about Christmas shopping habits. What else? People have returned to luxury goods, he said. Holidays and furniture are down a little bit though.

    06:04: Hacking 2.0
    Kim Jong

    The global cyberwar that dominated headlines last week shows no signs of abating. Hackers have infiltrated South Korea's nuclear power provider, and posted schematics of nuclear reactors and private personal records online. It's not clear whether the same group that attacked Sony Pictures is responsible.

    06:00: Howard Mustoe Business reporter

    Morning! Get in touch. Tell us what you think. Email bizlivepage@bbc.co.uk or on Twitter @BBCBusiness

    06:00: Joe Miller Business Reporter

    Good morning, and festive greetings all round. In a week when the business world is winding down for Christmas, we'll bring you all the news that's sneaking in the back door, and much more besides.



From BBC Capital


  • (File photo) A man dressed as Father Christmas with a sleigh and a reindeer Click Watch

    A website which tracks Father Christmas, plus other sites and apps to keep you entertained

BBC © 2014 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.